Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
AZ Boss Claims Coronavirus 'Very Contained', as China Locks Down Wuhan to Contro...
"It really looks like at this point it's very contained," AZ boss Pascal Soriot told CNBC on January 22, the same day the Chinese city of Wuhan was locked down ... (1/22/2020) (free)
   
US-China Trade Agreement—Pharma Impacts (1/23/2020)
AZ Boss Claims Coronavirus 'Very Contained', as China Locks Down Wuhan to Control Spread (1/22/2020) (free)
Celebrity Doctor Pay Exposes China's Healthcare Gap (1/22/2020)
Impact of the China-U.S. Trade Deal on Intellectual Property Protection (1/22/2020)
BeiGene: The Poster Child Of China's Booming Biopharma Market (1/22/2020)
Bayer to Focus More on R&D and Innovation in China (1/20/2020)
US, China Sign Phase One Trade Deal: How to Read the Agreement (1/17/2020)
Drugmakers Brace for China's Biggest-Ever Round of Price Cuts (1/16/2020)
Boehringer Ingelheim's Bet on Chinese CDMO Market Pays Off with Beigene's Mab Approval (1/6/2020) (free)
Chinese Scientist Extradited to Stand Trial in the US for Plot to Steal GSK Trade Secrets (1/6/2020)
Meeting Clinical Trial Data Requirements In Asian Markets (1/3/2020)
U.S.-China Phase I Trade Deal - An Opportunity Window MNCs Must Not Miss (1/2/2020)
Recent Announcement for A More Effective Intellectual Property Protection System in China (12/19/2019)
Takeda Aspires to Become A Top Ten MNC Pharma Co. in China (12/18/2019)
A Few Details on the US-China "Phase One" Trade Deal (12/16/2019)
Recent Executive Moves  (1/23/2020)
Financial-related Company News in Brief  (1/23/2020)
Gilead Assesses Ebola Drug as Possible C...  (1/23/2020) (free)
Onconova Therapeutics Regains Rigosertib...  (1/23/2020)
Amgen Pledges to Expand Asian Presence  (1/23/2020)
Roche's ADC Drug Kadcycla Approved in Ch...  (1/23/2020)
NIH: Coronavirus Vaccine Could Begin Hum...  (1/22/2020)
Moderna Is Working on A Vaccine for Chin...  (1/22/2020)
BeiGene Aims to Take on Merck's Star Ani...  (1/22/2020)
29 Domestics Filed 96 ANDAs in the U.S. ...  (1/21/2020)
NMPA Announces Implementation of Four Se...  (1/21/2020)
TB Alliance Licenses China Rights of Ant...  (1/21/2020)
Novotech: Asia-Pacific Had A Record Year...  (1/20/2020)
Chi-Med Reports Positive Surufatinib Pha...  (1/20/2020) (free)
Zydus and CMS enter into a License Agree...  (1/20/2020)
Pfizer to Absorb Mylan, Creating Global Generic Powerhou...
PhRMA Calls for Trade Deals That Force Countries to Pay ...
IQVIA: Global Pharma to Grow Slower in the Next Five Yea...
Pfizer and GSK Announce JV to Create a Global Consumer H...
Top 25 Global Pharmaceutical Companies by Market Cap 201...
PHIIC: Data Snapshots of Chinese Pharma Market 2013-2019E
Chinese Cancer Drug Market to Surpass $30+ Billion by 2025
NH Reports on Chinese OTC Sleep Aids Market in MAT Q3/2018
IQVIA: Chinese Hospital Drug Market Up 9.7% in MAT Q3/2019
IQVIA: Chinese Retail Pharmacy Sales Up 1.9% in Q3/2019
Financial-related Company News in Brief
Gilead Assesses Ebola Drug as Possible Coronavirus Treatment...
Onconova Therapeutics Regains Rigosertib Rights in Greater C...
Amgen Pledges to Expand Asian Presence
Roche's ADC Drug Kadcycla Approved in China
NMPA Announces Implementation of Four Series Q ICH Guide...
NMPA Publicizes List of Reference Formulations for Gener...
Review of Chinese Drug Registration Applications and App...
NMPA Issues Notice on Matters Relating to API Registrati...
NMPA Publicizes List of Reference Formulations for Gener...
U.S.-China Phase 1 Deal Hands Pharma MNCs A Major IPR Win
US, China Agree To Protect Patents, Fight Trade Secret Abuse...
China Jails Three Researchers Involved in Gene-edited Babies...
China Adopts New Law to Promote Basic Medical and Health Car...
Chinese Medical Researcher Investigated for Smuggling Vials ...
Nikkei: Japan's Generic Drugmakers Have A China Dependen...
Korea's Growing Reliance on China for API Supply Flagged...
WuXi STA's Jinshan Facility Passes EMA Inspection
Novartis Disposes Suzhou Novartis PharmTech in Changshu ...
FDA Warns Chinese API Producer Yino
NIH: Coronavirus Vaccine Could Begin Human Trials in Thr...
Moderna Is Working on A Vaccine for China’s Deadly Coro...
BeiGene Aims to Take on Merck's Star Aniticancer Drug Ke...
China-Based Ivy Capital Invests in Betagenon's Clinical ...
Ambrx and Sino Biopharma Announce Collaboration to Devel...
National Primary Healthcare Working Conference Highlight...
National Drug Registration and Post-marketing Surveillan...
Round 2 of the National Level Centralized Drug Purchase ...
Chinese Birthrate Falls To Lowest Level In 70 Years
China Issues Notice for Implementing National Level Cent...
Recent Executive Moves
Hengrui's Billionaire Founder Retires into the Backseat
Recent Executive Moves
Recent Executive Moves
Recent Executive Moves
U.S. and China Inks Phase One Trade Deal
Amid Trade War, China Lowers Import Tariffs on 850 Produ...
Upcoming Event: International Conference on Biosimilars ...
Upcoming Event: Biologics Manufacturing Asia 2020
Upcoming Event: Asia Wellness Expo 2020
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Publishes the China Phar...
  WiCON to Hold Pharma China Ann...
  WiCON Publishes the China Phar...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Chi...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links